CPRiL

C21H35N9O15P2

C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OC[C@@H]4[C@H]([C@H]([C@H](O4)NC(=NCCC[C@@H](C(=O)O)N)N)O)O)O)O)N

InChI=1S/C21H35N9O15P2/c22-8(20(35)36)2-1-3-25-21(24)29-18-14(33)12(31)9(43-18)4-41-46(37,38)45-47(39,40)42-5-10-13(32)15(34)19(44-10)30-7-28-11-16(23)26-6-27-17(11)30/h6-10,12-15,18-19,31-34H,1-5,22H2,(H,35,36)(H,37,38)(H,39,40)(H2,23,26,27)(H3,24,25,29)/t8-,9+,10+,12+,13+,14+,15+,18-,19+/m0/s1

• ADP-Ribosylarginine
• Nomega-(ADP-D-ribosyl)-L-arginine
• 103960-56-1
N(omega)-(ADP-D-ribosyl)-L-arginine
D5024CP23U
ADP-Ribosyl-L-arginine
alpha-ADP-ribosylarginine
UNII-D5024CP23U
adenosine 5'-{3-[1-(N(omega)-arginino)-1-deoxy-alpha-D-ribofuranos-5-yl] dihydrogen diphosphate}
L-Ornithine, N5-(((5-O-(hydroxy(phosphonooxy)phosphinyl)-alpha-D-ribofuranosyl)amino)iminomethyl)-, p'->5'-ester with adenosine
L-Ornithine, N5-(imino(alpha-D-ribofuranosylamino)methyl)-, (5'->p')-ester with adenosine 5'-(trihydrogen diphosphate)
L-Ornithine, N5-[imino(alpha-D-ribofuranosylamino)methyl]-, (5'-->P')-ester with adenosine 5'-(trihydrogen diphosphate)
CHEBI:15827
DTXSID801107506
.ALPHA.-ADP-RIBOSYLARGININE
AKOS040750151
C01201
Q27098247
(2S)-2-amino-5-[[amino-[[(2S,3R,4S,5R)-5-[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-3,4-dihydroxyoxolan-2-yl]amino]methylidene]amino]pentanoic acid
F2R
L-ORNITHINE, N5-(((5-O-(HYDROXY(PHOSPHONOOXY)PHOSPHINYL)-.ALPHA.-D-RIBOFURANOSYL)AMINO)IMINOMETHYL)-, P'->5'-ESTER WITH ADENOSINE
L-ORNITHINE, N5-(IMINO(.ALPHA.-D-RIBOFURANOSYLAMINO)METHYL)-, (5'->P')-ESTER WITH ADENOSINE 5'-(TRIHYDROGEN DIPHOSPHATE)
L-Ornithine, N5-[imino(I+/--D-ribofuranosylamino)methyl]-, (5a(2)aPa(2))-ester with adenosine 5a(2)-(trihydrogen diphosphate)